MENU
+Compare
INSM
Stock ticker: NASDAQ
AS OF
Aug 22 closing price
Price
$131.88
Change
-$0.72 (-0.54%)
Capitalization
27.88B

INSM Insmed Forecast, Technical & Fundamental Analysis

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases... Show more

Industry: #Biotechnology
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for INSM with price predictions
Aug 22, 2025

INSM's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for INSM turned positive on August 04, 2025. Looking at past instances where INSM's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 29, 2025. You may want to consider a long position or call options on INSM as a result. In of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INSM advanced for three days, in of 292 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 181 cases where INSM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 16 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INSM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

INSM broke above its upper Bollinger Band on August 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INSM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (22.321) is normal, around the industry mean (19.343). P/E Ratio (0.000) is within average values for comparable stocks, (54.752). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.643). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (59.880) is also within normal values, averaging (304.274).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

INSM is expected to report earnings to fall 20.00% to -136 cents per share on October 23

Insmed INSM Stock Earnings Reports
Q3'25
Est.
$-1.36
Q2'25
Missed
by $0.40
Q1'25
Missed
by $0.07
Q4'24
Missed
by $0.14
Q3'24
Missed
by $0.07
The last earnings report on August 07 showed earnings per share of -170 cents, missing the estimate of -129 cents. With 2.10M shares outstanding, the current market capitalization sits at 27.88B.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
700 US Highway 202/206
Phone
+1 908 977-9900
Employees
912
Web
https://www.insmed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PRFZ44.511.66
+3.86%
Invesco RAFI US 1500 Small-Mid ETF
ALTL40.451.26
+3.21%
Pacer Lunt Large Cap Alternator ETF
EFAX49.230.73
+1.50%
SPDR® MSCI EAFE Fssl Ful Free RsrvETF
PEX28.120.36
+1.31%
ProShares Global Listed Private Equity
FEGE42.430.47
+1.12%
FIRST EAGLE GLOBAL EQUITY ETF

INSM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, INSM has been closely correlated with THAR. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if INSM jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
-0.54%
THAR - INSM
74%
Closely correlated
-5.03%
CARM - INSM
43%
Loosely correlated
+2.88%
CRNX - INSM
41%
Loosely correlated
+5.17%
ROIV - INSM
41%
Loosely correlated
+0.93%
AXON - INSM
40%
Loosely correlated
+0.36%
More

Groups containing INSM

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
-0.54%
INSM
(2 stocks)
100%
Closely correlated
-2.79%